Operating income decreased 42.5%
Operating income changed -42.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -42.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +47.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Selling, general & administrative changed +33.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -5933 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed -57.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +10.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed +2061.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
SBC / revenue changed +140 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +15.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.